Important note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
|
|
Sexually Transmitted Infections Vol. 83; No. 6: P. 458-462 (10.01.07) - Wednesday, December 26, 2007
Steven M. Goodreau; Matthew R. Golden
The authors of the current study set out to identify how much these biological and demographic differences could explain persistent disparities in HIV/STD prevalence in the United States - even if MSM and heterosexuals report identical numbers of unprotected sexual partnerships per year. They created a compartmental model parameterized using two population-based surveys. Role composition was varied between MSM and heterosexual subjects (insertive-only and receptive only vs. versatile individuals) and infectivity values.
Considerable disparities in equilibrium prevalence resulted from the absence of sexual role segregation in MSM and differential anal/vaginal transmission probabilities. "The US heterosexual population would only experience an epidemic comparable to MSM if the mean partner number of heterosexual individuals was increased by several fold over that observed in population-based studies of either group," the authors wrote. "In order for MSM to eliminate the HIV epidemic, they would need to develop rates of unprotected sex lower than those currently exhibited by heterosexual individuals in the United States. In this model, for US heterosexual individuals to have a self-sustaining epidemic, they would need to adopt levels of unprotected sex higher than those currently exhibited by US MSM."
The authors concluded, "The persistence of disparities in HIV between heterosexual individuals and MSM in the United States cannot be explained solely by differences in risky sexual behavior between those two populations."
071226
AD072674
Copyright © 2007 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.